Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractional Shares

1,399.20
+9.900.71%
Number of Gainers:534
Number of Losers:489
Number of Flat:15
PE:- -
High:1,400.33
Open:1,389.31
Low:1,383.35
Close:1,389.30
Loading ...

It's Becoming a Better Time to Buy a Home -- If You Know Where to Look -- Barrons.com

Dow Jones
·
Yesterday

Breaking: SEC Approves April 30 Launch for XRP ETF by ProShares Trust

utoday
·
Yesterday

Bitcoin ETF Inflows Surge as Institutional Interest Accelerates

CoinMarketCap
·
Yesterday

Kevin Warsh Criticizes Federal Reserve's Communication Practices

CoinMarketCap
·
Yesterday

Ken Griffin Criticizes Trump's Tariff Strategy at Events

CoinMarketCap
·
Yesterday

$50 Trillion for Bitcoin (BTC)? Bitwise CEO Issues New Epic Prediction

utoday
·
Yesterday

Bank of America Spotlights Bitcoin's Massive Inflows

utoday
·
Yesterday

$8,000 in 20 Days? MAGACOINFINANCE.COM, XRP, SOLANA, and BITCOIN Are Building Momentum

CoinMarketCap
·
Yesterday

Crypto Sentiment Rises Amid Continued Weekend Liquidity Risks

CoinMarketCap
·
Yesterday

Gold ETFs saw a net outflow of $1.3 billion this Wednesday, marking the third largest outflow in history

Blockbeats
·
Yesterday

Can Bitcoin Hit $108,000? Bullish Fundamentals Suggest Yes

utoday
·
Yesterday

Amateur Athletes Are Turning to Ozempic to Raise Their Game -- WSJ

Dow Jones
·
Yesterday

China Square Food Centre set to be redeveloped into hotel; more homes to be built in the CBD, Kallang and River Valley

businesstimes
·
Yesterday

BRIEF-Medtronic PLC Says Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence

Reuters
·
Yesterday

Medtronic Plc - Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence

THOMSON REUTERS
·
Yesterday

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

PR Newswire
·
Yesterday

BRIEF-Abbott Laboratories Says New Clinical Study Data Showcase Long-Term, Sustained Benefits Of Abbott's Volt™ Pfa System For Patients With Afib

Reuters
·
Yesterday

Abbott Laboratories - Volt Pfa System Shows Strong 12-Month Results

THOMSON REUTERS
·
Yesterday

Abbott Laboratories - Only 2.7% Experienced Safety Endpoint Event After 12 Months

THOMSON REUTERS
·
Yesterday

Abbott Laboratories - 83.5% Paf and 58.1% Persaf Patients Arrhythmia-Free After 12 Months

THOMSON REUTERS
·
Yesterday